20/20 Biolabs, Inc. AIDX
0.22 USD +0.02 (+11.40%)
Nov 11, 2026, 2:56 PM EST
0.191 Day range 0.2249
0.18 52-week range 50.00
- YTD
- -99.09%
- 1 year
- -99.09%
AIDX revenue history
Revenue is income from the company’s ordinary business activities.
2,045,133 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 2,045,133 | 292,790 | 16.71% |
| FY 2024 | 2024-12-31 | 1,752,343 | 328,039 | 23.03% |
| FY 2023 | 2023-12-31 | 1,424,304 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:10.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.